{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:59:53Z","timestamp":1783490393213,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"publisher","award":["ADHS14-082988"],"award-info":[{"award-number":["ADHS14-082988"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012228","name":"Development and Reform Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20170306140638792"],"award-info":[{"award-number":["JCYJ20170306140638792"]}],"id":[{"id":"10.13039\/501100012228","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012228","name":"Development and Reform Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["GJHZ20180929145202083"],"award-info":[{"award-number":["GJHZ20180929145202083"]}],"id":[{"id":"10.13039\/501100012228","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00417-020-05043-6","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T15:03:36Z","timestamp":1611932616000},"page":"1529-1538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Topical administration of ambroxol eye drops augments tear secretion in rabbits"],"prefix":"10.1007","volume":"259","author":[{"given":"Li","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruva","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0259-3607","authenticated-orcid":false,"given":"Mingwu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"5043_CR1","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nelson JD, Azar DT et al (2017) TFOS DEWS II report executive summary. Ocul Surf 15:802\u2013812","journal-title":"Ocul Surf"},{"key":"5043_CR2","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1167\/iovs.08-3033","volume":"50","author":"J Ruiz-Ederra","year":"2009","unstructured":"Ruiz-Ederra J, Levin MH, Verkman AS (2009) In situ fluorescence measurement of tear film [Na+], [K+], [Cl-], and pH in mice shows marked hypertonicity in aquaporin-5 deficiency. Invest Ophthalmol Vis Sci 50:2132\u20132138","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5043_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1089\/jop.2011.0157","volume":"28","author":"WR Thelin","year":"2012","unstructured":"Thelin WR, Johnson MR, Hirsh AJ, Kublin CL, Zoukhri D (2012) Effect of topically applied epithelial sodium channel inhibitors on tear production in normal mice and in mice with induced aqueous tear deficiency. J Ocul Pharmacol Ther 28:433\u2013438","journal-title":"J Ocul Pharmacol Ther"},{"key":"5043_CR4","doi-asserted-by":"publisher","first-page":"7774","DOI":"10.1167\/iovs.15-17550","volume":"56","author":"D Bhattacharya","year":"2015","unstructured":"Bhattacharya D, Ning Y, Zhao F, Stevenson W, Chen R, Zhang J, Wang M (2015) Tear production after bilateral main lacrimal gland resection in rabbits. Invest Ophthalmol Vis Sci 56:7774\u20137783","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5043_CR5","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.survophthal.2016.02.006","volume":"61","author":"W Stevenson","year":"2016","unstructured":"Stevenson W, Pugazhendhi S, Wang M (2016) Is the main lacrimal gland indispensable? Contributions of the corneal and conjunctival epithelia. Surv Ophthalmol 61:616\u2013627","journal-title":"Surv Ophthalmol"},{"key":"5043_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/02713688809031801","volume":"7","author":"MA Watsky","year":"1988","unstructured":"Watsky MA, Jablonski MM, Edelhauser HF (1988) Comparison of conjunctival and corneal surface areas in rabbit and human. Curr Eye Res 7:483\u2013486","journal-title":"Curr Eye Res"},{"key":"5043_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S1350-9462(02)00038-1","volume":"21","author":"DA Dartt","year":"2002","unstructured":"Dartt DA (2002) Regulation of mucin and fluid secretion by conjunctival epithelial cells. Prog Retin Eye Res 21:555\u2013576","journal-title":"Prog Retin Eye Res"},{"key":"5043_CR8","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3109\/02713688509095259","volume":"4","author":"L Thorig","year":"1985","unstructured":"Thorig L, van Agtmaal EJ, Glasius E, Tan KL, van Haeringen NJ (1985) Comparison of tears and lacrimal gland fluid in the rabbit and guinea pig. Curr Eye Res 4:913\u2013920","journal-title":"Curr Eye Res"},{"key":"5043_CR9","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1167\/iovs.04-1314","volume":"46","author":"MH Levin","year":"2005","unstructured":"Levin MH, Verkman AS (2005) CFTR-regulated chloride transport at the ocular surface in living mice measured by potential differences. Invest Ophthalmol Vis Sci 46:1428\u20131434","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5043_CR10","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1076\/ceyr.21.4.782.5550","volume":"21","author":"T Murakami","year":"2000","unstructured":"Murakami T, Fujihara T, Nakamura M, Nakata K (2000) P2Y(2) receptor stimulation increases tear fluid secretion in rabbits. Curr Eye Res 21:782\u2013787","journal-title":"Curr Eye Res"},{"key":"5043_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000076887","volume":"36","author":"T Murakami","year":"2004","unstructured":"Murakami T, Fujihara T, Horibe Y, Nakamura M (2004) Diquafosol elicits increases in net Cl- transport through P2Y2 receptor stimulation in rabbit conjunctiva. Ophthalmic Res 36:89\u201393","journal-title":"Ophthalmic Res"},{"key":"5043_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1167\/iovs.05-1082","volume":"47","author":"MH Levin","year":"2006","unstructured":"Levin MH, Kim JK, Hu J, Verkman AS (2006) Potential difference measurements of ocular surface Na+ absorption analyzed using an electrokinetic model. Invest Ophthalmol Vis Sci 47:306\u2013316","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5043_CR13","first-page":"2279","volume":"16","author":"S Hara","year":"2010","unstructured":"Hara S, Hazama A, Miyake M et al (2010) The effect of topical amiloride eye drops on tear quantity in rabbits. Mol Vis 16:2279\u20132285","journal-title":"Mol Vis"},{"key":"5043_CR14","doi-asserted-by":"publisher","first-page":"3964642","DOI":"10.1155\/2016\/3964642","volume":"2016","author":"Y Ning","year":"2016","unstructured":"Ning Y, Bhattacharya D, Jones RE, Zhao F, Chen R, Zhang J, Wang M (2016) Evaluating the functionality of conjunctiva using a rabbit dry eye model. J Ophthalmol 2016:3964642","journal-title":"J Ophthalmol"},{"key":"5043_CR15","doi-asserted-by":"publisher","first-page":"e0187188","DOI":"10.1371\/journal.pone.0187188","volume":"12","author":"D Bhattacharya","year":"2017","unstructured":"Bhattacharya D, Yu L, Wang M (2017) Expression patterns of conjunctival mucin 5 AC and aquaporin 5 in response to acute dry eye stress. PLoS One 12:e0187188","journal-title":"PLoS One"},{"key":"5043_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.resp.2007.12.007","volume":"161","author":"Y Ben","year":"2008","unstructured":"Ben Y, Chen J, Zhu R, Gao L, Bai C (2008) Upregulation of AQP3 and AQP5 induced by dexamethasone and ambroxol in A549 cells. Respir Physiol Neurobiol 161:111\u2013118","journal-title":"Respir Physiol Neurobiol"},{"key":"5043_CR17","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1080\/14740338.2018.1533954","volume":"17","author":"D Cazan","year":"2018","unstructured":"Cazan D, Klimek L, Sperl A, Plomer M, Kolsch S (2018) Safety of ambroxol in the treatment of airway diseases in adult patients. Expert Opin Drug Saf 17:1211\u20131224","journal-title":"Expert Opin Drug Saf"},{"issue":"Suppl 1","key":"5043_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000195273","volume":"51","author":"J Germouty","year":"1987","unstructured":"Germouty J, Jirou-Najou JL (1987) Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses. Respiration 51(Suppl 1):37\u201341","journal-title":"Respiration"},{"key":"5043_CR19","first-page":"557","volume":"13","author":"KM Beeh","year":"2008","unstructured":"Beeh KM, Beier J, Esperester A, Paul LD (2008) Antiinflammatory properties of ambroxol. Eur J Med Res 13:557\u2013562","journal-title":"Eur J Med Res"},{"key":"5043_CR20","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.neuropharm.2005.08.004","volume":"49","author":"W Gaida","year":"2005","unstructured":"Gaida W, Klinder K, Arndt K, Weiser T (2005) Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain. Neuropharmacology 49:1220\u20131227","journal-title":"Neuropharmacology"},{"key":"5043_CR21","doi-asserted-by":"publisher","first-page":"DES116","DOI":"10.1167\/iovs.18-24130","volume":"59","author":"H Watanabe","year":"2018","unstructured":"Watanabe H (2018) Medical treatment for dry eye in Japan. Invest Ophthalmol Vis Sci 59:DES116\u2013DDES20","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5043_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1001\/jamainternmed.2017.7904","volume":"178","author":"LM Schwartz","year":"2018","unstructured":"Schwartz LM, Woloshin S (2018) A Clear-eyed view of restasis and chronic dry eye disease. JAMA Intern Med 178:181\u2013182","journal-title":"JAMA Intern Med"},{"key":"5043_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2147\/OPTH.S39061","volume":"7","author":"A Dota","year":"2013","unstructured":"Dota A, Takaoka-Shichijo Y, Nakamura M (2013) Gefarnate stimulates mucin-like glycoprotein secretion in conjunctival tissue and ameliorates corneal epithelial damage in animal dry-eye models. Clin Ophthalmol 7:211\u2013217","journal-title":"Clin Ophthalmol"},{"issue":"576-83","key":"5043_CR24","first-page":"e1","volume":"157","author":"S Kinoshita","year":"2014","unstructured":"Kinoshita S, Awamura S, Nakamichi N, Suzuki H, Oshiden K, Yokoi N, Rebamipide Ophthalmic Suspension Long-term Study G (2014) A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye. Am J Ophthalmol 157(576-83):e1","journal-title":"Am J Ophthalmol"},{"key":"5043_CR25","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/eye.2012.166","volume":"26","author":"K Kamiya","year":"2012","unstructured":"Kamiya K, Nakanishi M, Ishii R, Kobashi H, Igarashi A, Sato N, Shimizu K (2012) Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study. Eye (Lond) 26:1363\u20131368","journal-title":"Eye (Lond)"},{"key":"5043_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrn2400","volume":"9","author":"CW Bourque","year":"2008","unstructured":"Bourque CW (2008) Central mechanisms of osmosensation and systemic osmoregulation. Nat Rev Neurosci 9:519\u2013531","journal-title":"Nat Rev Neurosci"},{"key":"5043_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neulet.2005.10.058","volume":"395","author":"T Weiser","year":"2006","unstructured":"Weiser T (2006) Comparison of the effects of four Na+ channel analgesics on TTX-resistant Na+ currents in rat sensory neurons and recombinant Nav1.2 channels. Neurosci Lett 395:179\u2013184","journal-title":"Neurosci Lett"},{"key":"5043_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/gb-2003-4-3-207","volume":"4","author":"FH Yu","year":"2003","unstructured":"Yu FH, Catterall WA (2003) Overview of the voltage-gated sodium channel family. Genome Biol 4:207","journal-title":"Genome Biol"},{"key":"5043_CR29","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/cbin.10146","volume":"37","author":"G Varelogianni","year":"2013","unstructured":"Varelogianni G, Hussain R, Strid H, Oliynyk I, Roomans GM, Johannesson M (2013) The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells. Cell Biol Int 37:1149\u20131156","journal-title":"Cell Biol Int"},{"key":"5043_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1039\/B810471A","volume":"5","author":"BK Berdiev","year":"2009","unstructured":"Berdiev BK, Qadri YJ, Benos DJ (2009) Assessment of the CFTR and ENaC association. Mol BioSyst 5:123\u2013127","journal-title":"Mol BioSyst"},{"key":"5043_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002329900492","volume":"168","author":"K Kunzelmann","year":"1999","unstructured":"Kunzelmann K, Schreiber R (1999) CFTR, a regulator of channels. J Membr Biol 168:1\u20138","journal-title":"J Membr Biol"},{"key":"5043_CR32","first-page":"L1141","volume":"302","author":"JF Collawn","year":"2012","unstructured":"Collawn JF, Lazrak A, Bebok Z, Matalon S (2012) The CFTR and ENaC debate: how important is ENaC in CF lung disease? Am J Phys Lung Cell Mol Phys 302:L1141\u2013L1146","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"5043_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0074-7696(03)31001-0","volume":"231","author":"IK Gipson","year":"2003","unstructured":"Gipson IK, Argueso P (2003) Role of mucins in the function of the corneal and conjunctival epithelia. Int Rev Cytol 231:1\u201349","journal-title":"Int Rev Cytol"},{"key":"5043_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0049-3848(01)00412-1","volume":"105","author":"G Anfossi","year":"2002","unstructured":"Anfossi G, Russo I, Massucco P, Mattiello L, Cavalot F, Balbo A, Trovati M (2002) Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. Thromb Res 105:71\u201378","journal-title":"Thromb Res"},{"key":"5043_CR35","first-page":"1381","volume":"31","author":"JP Gilbard","year":"1990","unstructured":"Gilbard JP, Rossi SR, Heyda KG, Dartt DA (1990) Stimulation of tear secretion by topical agents that increase cyclic nucleotide levels. Invest Ophthalmol Vis Sci 31:1381\u20131388","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5043_CR36","doi-asserted-by":"publisher","unstructured":"Wang L, Yu L, Li N et al (2019) Bromhexine elevates REP2 expression to stimulate secretion from human primary conjunctiva fornix epithelial cells. FEBS Lett. https:\/\/doi.org\/10.1002\/1873-3468.13560","DOI":"10.1002\/1873-3468.13560"},{"key":"5043_CR37","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s12272-013-0210-7","volume":"37","author":"M Yamaya","year":"2014","unstructured":"Yamaya M, Nishimura H, Nadine LK, Ota C, Kubo H, Nagatomi R (2014) Ambroxol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Arch Pharm Res 37:520\u2013529","journal-title":"Arch Pharm Res"},{"key":"5043_CR38","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.exer.2003.10.024","volume":"78","author":"J Gao","year":"2004","unstructured":"Gao J, Morgan G, Tieu D, Schwalb TA, Luo JY, Wheeler LA, Stern ME (2004) ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjogrens syndrome-like MRL\/lpr mice. Exp Eye Res 78:823\u2013835","journal-title":"Exp Eye Res"},{"key":"5043_CR39","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK et al (2017) TFOS DEWS II pathophysiology report. Ocul Surf 15:438\u2013510","journal-title":"Ocul Surf"},{"key":"5043_CR40","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s000110050421","volume":"48","author":"BF Gibbs","year":"1999","unstructured":"Gibbs BF, Schmutzler W, Vollrath IB, Brosthardt P, Braam U, Wolff HH, Zwadlo-Klarwasser G (1999) Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells. Inflamm Res 48:86\u201393","journal-title":"Inflamm Res"},{"issue":"Suppl 3","key":"5043_CR41","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1007\/s00482-015-0060-y","volume":"29","author":"KU Kern","year":"2015","unstructured":"Kern KU, Weiser T (2015) Topical ambroxol for the treatment of neuropathic pain. An initial clinical observation. Schmerz 29(Suppl 3):S89\u2013S96","journal-title":"Schmerz"},{"key":"5043_CR42","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","volume":"15","author":"C Belmonte","year":"2017","unstructured":"Belmonte C, Nichols JJ, Cox SM et al (2017) TFOS DEWS II pain and sensation report. Ocul Surf 15:404\u2013437","journal-title":"Ocul Surf"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-05043-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-020-05043-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-05043-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T17:02:12Z","timestamp":1697734932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-020-05043-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5043"],"URL":"https:\/\/doi.org\/10.1007\/s00417-020-05043-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"9 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Mingwu Wang holds US, Canadian, Korean\u00a0and Australian patents for topical application of ambroxol for treatment of ocular surface diseases. The other authors have no commercial or proprietary interest in any concept or products described in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The protocol was approved by the University of Arizona (Tucson, AZ, USA) and Shenzhen Eye Hospital Institutional Animal Care and Use Committees (Shenzhen, Guangdong, China). The study was conducted in compliance with the Tenets of the Declaration of Helsinki and the Association for Research in Vision and Ophthalmology statement for the use of animals in ophthalmic and visual research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors consent to the submission of the manuscript for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official views of the government funding agencies or other funders.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}